Global Latent Tuberculosis Infection (LTBI) Testing Market Research Report 2026(Status and Outlook)

February 2026 | 136 pages | ID: GCBEDA09E27AEN
Bosson Research

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.The detection industry of latent tuberculosis infection (LTBI) can be subdivided into several parts: tuberculin skin test (TST), interferon release test (IGRA), etc.Globally, there are mainly Qiagen, Oxford Immunotec, Sanofi, etc.Diagnosing and treating latent tuberculosis infection (LTBI) is an important strategy recognized by the World Health Organization to accelerate the decline of global tuberculosis and achieve the elimination of tuberculosis. Latent tuberculosis infection (LTBI) refers to the state of continuous immune response to the stimulation of Mycobacterium tuberculosis antigen in the absence of clinical evidence of active tuberculosis (TB). The diagnosis and treatment of long-term tuberculosis is very important for tuberculosis, especially for high-risk groups. Tuberculin skin tests (TST) and interferon release tests (IGRAs) were used to diagnose LTBI.

The global Latent Tuberculosis Infection (LTBI) Testing market size was estimated at USD 1550.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.40% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Latent Tuberculosis Infection (LTBI) Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Latent Tuberculosis Infection (LTBI) Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Latent Tuberculosis Infection (LTBI) Testing market.

Global Latent Tuberculosis Infection (LTBI) Testing Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories

Market Segmentation (by Type)

Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)

Market Segmentation (by Application)

Hospitals and Clinics
Diagnostic Laboratories
Others

Geographic Segmentation

North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Latent Tuberculosis Infection (LTBI) Testing Market
Overview of the regional outlook of the Latent Tuberculosis Infection (LTBI) Testing Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Latent Tuberculosis Infection (LTBI) Testing Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Latent Tuberculosis Infection (LTBI) Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Latent Tuberculosis Infection (LTBI) Testing
1.2 Key Market Segments
  1.2.1 Latent Tuberculosis Infection (LTBI) Testing Segment by Type
  1.2.2 Latent Tuberculosis Infection (LTBI) Testing Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Latent Tuberculosis Infection (LTBI) Testing Product Life Cycle
3.3 Global Latent Tuberculosis Infection (LTBI) Testing Sales by Manufacturers (2020-2025)
3.4 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Latent Tuberculosis Infection (LTBI) Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Latent Tuberculosis Infection (LTBI) Testing Market Competitive Situation and Trends
  3.8.1 Latent Tuberculosis Infection (LTBI) Testing Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Latent Tuberculosis Infection (LTBI) Testing Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING INDUSTRY CHAIN ANALYSIS

4.1 Latent Tuberculosis Infection (LTBI) Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Latent Tuberculosis Infection (LTBI) Testing Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Latent Tuberculosis Infection (LTBI) Testing Market
5.7 ESG Ratings of Leading Companies

6 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Type (2020-2025)
6.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
6.4 Global Latent Tuberculosis Infection (LTBI) Testing Price by Type (2020-2025)

7 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Sales by Application (2020-2025)
7.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Latent Tuberculosis Infection (LTBI) Testing Sales Growth Rate by Application (2020-2025)

8 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET SALES BY REGION

8.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales by Region
  8.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales by Region
  8.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region
8.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region
  8.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region
  8.2.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region
8.3 North America
  8.3.1 North America Latent Tuberculosis Infection (LTBI) Testing Sales by Country
  8.3.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Latent Tuberculosis Infection (LTBI) Testing Sales by Country
  8.4.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales by Region
  8.5.2 Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Latent Tuberculosis Infection (LTBI) Testing Sales by Country
  8.6.2 South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales by Region
  8.7.2 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET PRODUCTION BY REGION

9.1 Global Production of Latent Tuberculosis Infection (LTBI) Testing by Region(2020-2025)
9.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Region (2020-2025)
9.3 Global Latent Tuberculosis Infection (LTBI) Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Latent Tuberculosis Infection (LTBI) Testing Production
  9.4.1 North America Latent Tuberculosis Infection (LTBI) Testing Production Growth Rate (2020-2025)
  9.4.2 North America Latent Tuberculosis Infection (LTBI) Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Latent Tuberculosis Infection (LTBI) Testing Production
  9.5.1 Europe Latent Tuberculosis Infection (LTBI) Testing Production Growth Rate (2020-2025)
  9.5.2 Europe Latent Tuberculosis Infection (LTBI) Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Latent Tuberculosis Infection (LTBI) Testing Production (2020-2025)
  9.6.1 Japan Latent Tuberculosis Infection (LTBI) Testing Production Growth Rate (2020-2025)
  9.6.2 Japan Latent Tuberculosis Infection (LTBI) Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Latent Tuberculosis Infection (LTBI) Testing Production (2020-2025)
  9.7.1 China Latent Tuberculosis Infection (LTBI) Testing Production Growth Rate (2020-2025)
  9.7.2 China Latent Tuberculosis Infection (LTBI) Testing Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Qiagen
  10.1.1 Qiagen Basic Information
  10.1.2 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Overview
  10.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
  10.1.4 Qiagen Business Overview
  10.1.5 Qiagen SWOT Analysis
  10.1.6 Qiagen Recent Developments
10.2 Sanofi
  10.2.1 Sanofi Basic Information
  10.2.2 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Overview
  10.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
  10.2.4 Sanofi Business Overview
  10.2.5 Sanofi SWOT Analysis
  10.2.6 Sanofi Recent Developments
10.3 Oxford Immunotec
  10.3.1 Oxford Immunotec Basic Information
  10.3.2 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Overview
  10.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
  10.3.4 Oxford Immunotec Business Overview
  10.3.5 Oxford Immunotec SWOT Analysis
  10.3.6 Oxford Immunotec Recent Developments
10.4 Thermo Fisher Scientific
  10.4.1 Thermo Fisher Scientific Basic Information
  10.4.2 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Overview
  10.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
  10.4.4 Thermo Fisher Scientific Business Overview
  10.4.5 Thermo Fisher Scientific Recent Developments
10.5 Par Sterile
  10.5.1 Par Sterile Basic Information
  10.5.2 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Overview
  10.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
  10.5.4 Par Sterile Business Overview
  10.5.5 Par Sterile Recent Developments
10.6 Bio-Rad Laboratories
  10.6.1 Bio-Rad Laboratories Basic Information
  10.6.2 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Overview
  10.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
  10.6.4 Bio-Rad Laboratories Business Overview
  10.6.5 Bio-Rad Laboratories Recent Developments

11 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET FORECAST BY REGION

11.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast
11.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country
  11.2.3 Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Region
  11.2.4 South America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Latent Tuberculosis Infection (LTBI) Testing by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Latent Tuberculosis Infection (LTBI) Testing by Type (2026-2035)
  12.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Latent Tuberculosis Infection (LTBI) Testing by Type (2026-2035)
12.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Application (2026-2035)
  12.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) Forecast by Application
  12.2.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS


LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (M USD)
Table 4. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
Table 5. Latent Tuberculosis Infection (LTBI) Testing Market Size Comparison by Region (M USD)
Table 6. Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection (LTBI) Testing as of 2025)
Table 11. Global Market Latent Tuberculosis Infection (LTBI) Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Latent Tuberculosis Infection (LTBI) Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Latent Tuberculosis Infection (LTBI) Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Latent Tuberculosis Infection (LTBI) Testing Sales by Type (K Units)
Table 27. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (M USD)
Table 28. Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Type (2020-2025)
Table 30. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Type (2020-2025)
Table 32. Global Latent Tuberculosis Infection (LTBI) Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) by Application
Table 34. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
Table 35. Global Latent Tuberculosis Infection (LTBI) Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Application (2020-2025)
Table 37. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
Table 39. Global Latent Tuberculosis Infection (LTBI) Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Latent Tuberculosis Infection (LTBI) Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region (2020-2025)
Table 42. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2020-2025)
Table 44. North America Latent Tuberculosis Infection (LTBI) Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Latent Tuberculosis Infection (LTBI) Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Latent Tuberculosis Infection (LTBI) Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Latent Tuberculosis Infection (LTBI) Testing Production (K Units) by Region(2020-2025)
Table 55. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Latent Tuberculosis Infection (LTBI) Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Latent Tuberculosis Infection (LTBI) Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Latent Tuberculosis Infection (LTBI) Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Latent Tuberculosis Infection (LTBI) Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Latent Tuberculosis Infection (LTBI) Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Qiagen Basic Information
Table 63. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 64. Qiagen Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Qiagen Business Overview
Table 66. Qiagen SWOT Analysis
Table 67. Qiagen Recent Developments
Table 68. Sanofi Basic Information
Table 69. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 70. Sanofi Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Sanofi Business Overview
Table 72. Sanofi SWOT Analysis
Table 73. Sanofi Recent Developments
Table 74. Oxford Immunotec Basic Information
Table 75. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 76. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Oxford Immunotec Business Overview
Table 78. Oxford Immunotec SWOT Analysis
Table 79. Oxford Immunotec Recent Developments
Table 80. Thermo Fisher Scientific Basic Information
Table 81. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 82. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Thermo Fisher Scientific Business Overview
Table 84. Thermo Fisher Scientific Recent Developments
Table 85. Par Sterile Basic Information
Table 86. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 87. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Par Sterile Business Overview
Table 89. Par Sterile Recent Developments
Table 90. Bio-Rad Laboratories Basic Information
Table 91. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Overview
Table 92. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Bio-Rad Laboratories Business Overview
Table 94. Bio-Rad Laboratories Recent Developments
Table 95. Global Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 96. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 97. North America Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 98. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 99. Europe Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 100. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 101. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 102. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 103. South America Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 104. South America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 105. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Country (2026-2035) & (Units)
Table 106. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 107. Global Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 108. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 109. Global Latent Tuberculosis Infection (LTBI) Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 110. Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) Forecast by Application (2026-2035)
Table 111. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Application (2026-2035) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Latent Tuberculosis Infection (LTBI) Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD), 2025-2035
Figure 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) (2020-2035)
Figure 6. Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Latent Tuberculosis Infection (LTBI) Testing Product Life Cycle
Figure 13. Latent Tuberculosis Infection (LTBI) Testing Sales Share by Manufacturers in 2025
Figure 14. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Manufacturers in 2025
Figure 15. Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Latent Tuberculosis Infection (LTBI) Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2025
Figure 18. Industry Chain Map of Latent Tuberculosis Infection (LTBI) Testing
Figure 19. Global Latent Tuberculosis Infection (LTBI) Testing Market PEST Analysis
Figure 20. Global Latent Tuberculosis Infection (LTBI) Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Type
Figure 27. Sales Market Share of Latent Tuberculosis Infection (LTBI) Testing by Type (2020-2025)
Figure 28. Sales Market Share of Latent Tuberculosis Infection (LTBI) Testing by Type in 2025
Figure 29. Market Share of Latent Tuberculosis Infection (LTBI) Testing by Type (2020-2025)
Figure 30. Market Share of Latent Tuberculosis Infection (LTBI) Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application
Figure 33. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Application in 2025
Figure 35. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application (2020-2025)
Figure 36. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Application in 2025
Figure 37. Global Latent Tuberculosis Infection (LTBI) Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2020-2025)
Figure 40. North America Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Country in 2024
Figure 43. North America Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country in 2024
Figure 45. U.S. Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Latent Tuberculosis Infection (LTBI) Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Country in 2024
Figure 53. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country in 2024
Figure 55. Germany Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region in 2024
Figure 68. China Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (K Units)
Figure 79. South America Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Country in 2024
Figure 80. South America Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (M USD)
Figure 81. South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country in 2024
Figure 82. Brazil Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Latent Tuberculosis Infection (LTBI) Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Latent Tuberculosis Infection (LTBI) Testing Production Market Share by Region (2020-2025)
Figure 103. North America Latent Tuberculosis Infection (LTBI) Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Latent Tuberculosis Infection (LTBI) Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Latent Tuberculosis Infection (LTBI) Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Latent Tuberculosis Infection (LTBI) Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Latent Tuberculosis Infection (LTBI) Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Application (2026-2035)


More Publications